StockVS

NASDAQ · Advertising Agencies · USD

Haoxi Health Technology Limited (HAO) Stock Analysis

Haoxi Health Technology Limited (HAO) is a Advertising Agencies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

HAO

$1.95

−$0.19 (−8.88%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HAO with… →

HAO Key Statistics

As of Oct 21, 2026
Trading
Open
$2.12
Previous Close
$2.14
Day's Range
1.95–2.12
52-Week Range
1.95–4,352.00
Volume
12.13K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−1.08
Valuation
Market Cap
$713.95K
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−386.40
Financials (FY)
Revenue (FY)
$48.52M+71.88%
Net Income (FY)
$1.29M+33.20%
Profit marginThe share of revenue left as profit after all costs and taxes.
−17.39%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
350.23K
1-Year Return
−99.93%
Dividend and dates
Avg Volume
219.78K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, HAO closed at $1.95, −99.93% over 1 year.

Haoxi Health Technology Limited (HAO) has a market capitalization of $713.95K.

In fiscal 2024, HAO reported revenue of $48.52M.

HAO Stock Return by Calendar Year

Haoxi Health Technology Limited (HAO) return since Jan 2024: what $10,000 became

1 year
$10,000 $7
−99.93%
Since Jan 2024
$10,000 $1
−99.99%

If you had invested $10,000 in Haoxi Health Technology Limited (HAO) at the close on January 26, 2024, the earliest close on record here, it would have been worth $1 at the close on October 21, 2026: −99.99% in total, −96.06% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−99.93%
2025+613.33%
2024−97.16%

As of October 21, 2026.

HAO Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2024$48.52M$1.29M2.7%
2023$28.23M$969.75K3.4%
2022$16.16M$244.59K1.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2024$48.52M$2.75M$1.72M$1.29M2.7%
2023$28.23M$2.06M$1.20M$969.75K3.4%
2022$16.16M$648.72K$268.77K$244.59K1.5%

Annual figures as reported, in the company's reporting currency. As of June 30, 2024.

HAO Valuation vs Advertising Agencies Median

Median of 41 stocks
MetricHAOAdvertising Agencies medianvs median
P/S ratio0.010.740.0x the median
Profit margin−17.39%−4.62%12.8 pts below

Medians across 41 Advertising Agencies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

The market values Haoxi Health Technology Limited (HAO) at $713.95K. It is classified in the Advertising Agencies industry, within the Communication Services sector. Headcount on file is 28.

HAO last closed at $1.95 on October 21, 2026. That is −$0.19 (−8.88%) against the previous close. Over the past 52 weeks the price has ranged from $1.95 to $4,352.00.

Financial Health

Fiscal 2024 revenue came to $48.52M. That is +71.88% against the prior fiscal year, when revenue was $28.23M. The same year closed with net income of $1.29M. That is +33.20% against the prior fiscal year. Profit margin runs at −17.39%. That is 12.8 percentage points below the Advertising Agencies median of −4.62%. Trailing earnings per share are −386.4.

Across the 3 fiscal years on file, revenue moves from $16.16M in 2022 to $48.52M in 2024. Of those 3 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Beta against the wider market is reported at −1.08. Annualized volatility over the trailing 2 years is 1,664.46%. The trailing one-year total return is −99.93%. The stored price history starts on January 26, 2024, and the total return since then is −99.99%.

Growth & Income

No dividend is on file for HAO.

The strongest complete calendar year on file is 2025 at +613.33%; the weakest is 2024 at −97.16%. 2026 is still running; the total return is −99.93% year to date.

Peer Comparison

Haoxi Health Technology Limited (HAO) operates in the Advertising Agencies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Haoxi Health Technology Limited HAO $713.95K —
AppLovin Corporation APP $90.00B 20.6
Omnicom Group Inc. OMC $22.08B 211.8
The Trade Desk, Inc. TTD $5.95B 15.2

The Advertising Agencies industry average P/E ratio is 27.7x. Haoxi Health Technology Limited has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Advertising Agencies Stocks

View all Advertising Agencies stocks →

Popular Communication Services Stocks

View all Communication Services stocks →

About Haoxi Health Technology Limited

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.

Visit website →